Titan Pharmaceuticals, Inc.
Price Action
Technical Summary
DOWNTRENDTitan Pharmaceuticals, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 17), showing significant lag compared to the market leaders. Earnings growth of 72% provides fundamental context to the price action. Investors should exercise caution due to high volatility (123% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $3.22 | -4.30% | BELOW |
| 50 SMA | $4.85 | -36.49% | BELOW |
| 100 SMA | $— | — | |
| 150 SMA | $— | — | |
| 200 SMA | $4.37 | -29.44% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is TTNP in an uptrend right now?
TTNP has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is TTNP overbought or oversold?
TTNP's RSI (14) is 43. The stock is in neutral territory, neither overbought nor oversold.
Is TTNP outperforming the market?
TTNP has a Relative Strength (RS) Rating of 17 out of 99. TTNP is currently lagging the broader market.
Where is TTNP in its 52-week range?
TTNP is trading at $3.08, which is 8% of its 52-week high ($39.00) and 1% above its 52-week low ($2.81).
How volatile is TTNP?
TTNP has a Beta of 1.77 and 52-week volatility of 123%. It's more volatile than the S&P 500 - expect bigger swings.